Compare stocks

Tecan Group AG is a Swiss company specializing in laboratory instruments and solutions within the life sciences sector. The company offers a range of automated workflow and instrumentation solutions for laboratories involved in diagnostics, bio-pharmaceuticals, and forensics. Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan operates globally, serving clients across various continents. The company's strategic positioning lies in its emphasis on automation and high-throughput systems, which cater to the growing demand for efficiency in laboratory settings. Tecan's products are characterized by their precision and adaptability, allowing for integration into diverse laboratory environments.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.